Fluidigm Announces Technical Breakthrough that Solves Fundamental Obstacle With Mircofluidics in Life Science

Fluidigm Corporation has achieved another first in microfluidics—a matrix chip architecture that enables both a high density of experiments (2,304 per chip) and effective mixing of nano-volume scale fluids. The new chip will allow Fluidigm to enter end-point PCR detection markets, such as SNP genotyping, which require both high-throughput and fully mixed reaction components.

Source: Fluidigm Corporation